Page last updated: 2024-12-05

2,2,2-trichloroethanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID8259
CHEMBL ID1171
CHEBI ID28094
SCHEMBL ID1027
MeSH IDM0047662

Synonyms (63)

Synonym
2,2,2-trichloro-ethanol
gtpl2293
CHEBI:28094 ,
2,2,2-trichloro-1-ethanol
brn 1697495
ccris 6763
2,2,2-trichloroethyl alcohol
einecs 204-071-0
nsc 66407
nsc-66407
(hydroxymethyl)trichloromethane
.beta.-trichloroethanol
trichloroethyl alcohol
wln: q1xggg
nsc66407
2,2-trichloroethanol
2,2-trichloro-1-ethanol
trichlorethanol
2,2-trichloroethyl alcohol
.beta.,.beta.,.beta-trichloroethanol
inchi=1/c2h3cl3o/c3-2(4,5)1-6/h6h,1h
ethanol,2,2,2-trichloro
ethanol, 2,2,2-trichloro-
115-20-8
trichloroethanol
C07490
2,2,2-trichloroethanol ,
2,2,2-trichloroethanol, reagentplus(r), >=99%
4YAS
CHEMBL1171
T0622
AKOS016010272
aw835aj62n ,
unii-aw835aj62n
FT-0609028
2,2,2-trichloroethanol [who-dd]
2,2,2-trichloroethanol [mi]
2,2,2-trichloroethan-1-ol
SCHEMBL1027
beta-trichloroethanol
2,2,2-trichloroethanoi
2,2,2-trichloro ethanol
Q-200151
ccl3ch2oh
STR02056
DTXSID1021950
mfcd00004677
2,2,2-trichloroethanol, purum, >=98.0% (gc)
2,2,2-trichloroethanol, vetec(tm) reagent grade, 98%
2,2,2-trichloroethanol (acd/name 4.0)
2, 2,2-trichloroethanol
beta,beta,.beta-trichloroethanol
8fh ,
2,2,2-tris-chloroethanol
Q4596742
2,2,2-trichloroethanol purum
AMY25535
EN300-120004
trichloroethanol;trichloroethyl alcohol
BCP32905
CS-0013285
D70779
HY-B1500

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Chlorate hydrate is commonly used for neonatal sedation, but blood levels are infrequently monitored, reflecting an underemphasis of acute toxic effects."( Chloral hydrate toxicity in a term infant.
Anyebuno, MA; Rosenfeld, CR, 1991
)
0.28
" This pattern is consistent with formation of the toxic intermediate in the primary metabolic pathway of each compound."( Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene: a dose-effect study.
Buben, JA; O'Flaherty, EJ, 1985
)
0.27
" Administered TFE and TFAld were not toxic per se, since their toxicity and metabolism were inhibited by pyrazole."( 2,2,2-Trifluoroethanol intestinal and bone marrow toxicity: the role of its metabolism to 2,2,2-trifluoroacetaldehyde and trifluoroacetic acid.
Fraser, JM; Kaminsky, LS, 1988
)
0.27
" These results indicated that TCE is metabolized in the male reproductive tract, leading to adverse effects that are more severe in the epididymis than in the testis."( Metabolism and toxicity of trichloroethylene in epididymis and testis.
Forkert, PG; Lash, LH; Nadeau, V; Simmonds, A; Tardif, R, 2002
)
0.31

Pharmacokinetics

ExcerptReferenceRelevance
"A six-compartment physiologically based pharmacokinetic (PBPK) model for the B6C3F1 mouse was developed for trichloroethylene (TCE) and was linked with five metabolite submodels consisting of four compartments each."( A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.
Abbas, R; Fisher, JW, 1997
)
0.3
"Using the Monte Carlo method and physiologically based pharmacokinetic modeling, an occupational inhalation exposure to trichloroethylene consisting of 7 h of exposure per day for 5 days was simulated in populations of men and women of 5000 individuals each."( Combining physiologically based pharmacokinetic modeling with Monte Carlo simulation to derive an acute inhalation guidance value for trichloroethylene.
Simon, TW, 1997
)
0.3
" Blood, urine, and exhaled breath samples were collected for development of a physiologically based pharmacokinetic (PBPK) model for trichloroethylene and its two major P450-mediated metabolites, trichloroacetic acid and free trichloroethanol."( A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.
Abbas, R; Fisher, JW; Mahle, D, 1998
)
0.3
"A physiologically based pharmacokinetic (PBPK) model for inhaled trichloroethylene (TCE) was developed for B6C3F1 mice."( Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice.
Burton, GA; Fisher, JW; Greenberg, MS, 1999
)
0.3
"Bayesian population analysis of a harmonized physiologically based pharmacokinetic (PBPK) model for trichloroethylene (TCE) and its metabolites was performed."( Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites.
Chiu, WA; Clewell, HJ; Hack, CE; Jay Zhao, Q, 2006
)
0.33

Dosage Studied

ExcerptRelevanceReference
" Dose-response curves were obtained using mice at pressures ranging from 1 to 125 atm for five agents, namely alpha-chloralose, ethylcarbamate, phenobarbital and, for comparison, nitrogen and argon."( The pressure reversal of a variety of anesthetic agents in mice.
Miller, KW; Wilson, MW, 1978
)
0.26
" The method has been used to determine plasma levels after therapeutic dosing with chloral preparations."( Determination of trichloroethanol at therapeutic and overdose levels in blood and urine by electron capture gas chromatography.
Berry, DJ, 1975
)
0.25
" Recommendations are made concerning patient supervision, dosage limitations, and degree of sedation."( Death after chloral hydrate sedation: report of case.
Jastak, JT; Pallasch, T, 1988
)
0.27
" Jugular vein, duodenum, and bile duct-cannulated Fischer 344 rats were used, with the collection of blood, bile, urine, and feces samples after intraduodenal and intravenous dosing of animals with TRI, TCEOH, and TCA."( Enterohepatic recirculation of trichloroethanol glucuronide as a significant source of trichloroacetic acid. Metabolites of trichloroethylene.
Bull, RJ; Merdink, JL; Springer, DL; Stenner, RD; Stevens, DK, 1997
)
0.3
" For oral bolus dosing of TCE with 300, 600, and 2000 mg/kg, model predictions of TCE and several metabolites were in general agreement with observations."( A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.
Abbas, R; Fisher, JW, 1997
)
0.3
" Male B6C3F1 mice were dosed with TRI, CH, trichloroethanol (TCE), or TCA and metabolic profiles of each were determined."( The extent of dichloroacetate formation from trichloroethylene, chloral hydrate, trichloroacetate, and trichloroethanol in B6C3F1 mice.
Bull, RJ; Gonzalez-Leon, A; Merdink, JL; Schultz, IR, 1998
)
0.3
" Additional male mice were dosed as described above and their livers were excised at 24, 48 h, and 7 days after the final dose."( Tumorigenicity of chloral hydrate, trichloroacetic acid, trichloroethanol, malondialdehyde, 4-hydroxy-2-nonenal, crotonaldehyde, and acrolein in the B6C3F(1) neonatal mouse.
Bucci, TJ; Chou, MW; Fu, PP; Kadlubar, FF; Samokyszyn, VM; Von Tungeln, LS; Yi, P, 2002
)
0.31
" On the other hand, tissue repair showed a dose-response leading to regression of injury."( Dose-dependent liver regeneration in chloroform, trichloroethylene and allyl alcohol ternary mixture hepatotoxicity in rats.
Anand, SS; Mehendale, HM; Mumtaz, MM, 2005
)
0.33
" This analysis provides an important step toward estimating uncertainty of dose-response relationships in noncancer and cancer risk assessment, improving the extrapolation of toxic TCE doses from experimental animals to humans."( Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites.
Chiu, WA; Clewell, HJ; Hack, CE; Jay Zhao, Q, 2006
)
0.33
" We have examined the dose-response relationship for formic aciduria in male and female Fischer 344 rats, the effect of some known metabolites of TCE and examined the response in male Wistar rats to help understand its relevance to renal toxicity."( Trichloroethylene-induced formic aciduria: effect of dose, sex and strain of rat.
Evans, AR; Lock, EA; Yaqoob, N, 2013
)
0.39
" Oral dosing with TCE was conducted in subacute (600 mg/kg/d; 5 d; 7 inbred mouse strains) and subchronic (100 or 400 mg/kg/d; 1, 2, or 4 wk; 2 inbred mouse strains) designs."( Comparative analysis of the relationship between trichloroethylene metabolism and tissue-specific toxicity among inbred mouse strains: liver effects.
Ball, LM; Bodnar, WM; Bradford, BU; Collins, LB; Gold, A; Kosyk, O; Rusyn, I; Shymonyak, S; Uehara, T; Yoo, HS, 2015
)
0.42
" Oral dosing with TCE was conducted in subacute (600 mg/kg/d; 5 d; 7 inbred mouse strains) and subchronic (100 or 400 mg/kg/d; 1, 2, or 4 wk; 2 inbred mouse strains) designs."( Comparative analysis of the relationship between trichloroethylene metabolism and tissue-specific toxicity among inbred mouse strains: kidney effects.
Ball, LM; Bodnar, WM; Bradford, BU; Collins, LB; Gold, A; Kosyk, O; Rusyn, I; Shymonyak, S; Uehara, T; Yoo, HS, 2015
)
0.42
" This new method can be applied for the pharmacokinetic analysis of TCS and its metabolites and the determination of the optimal TCS dosage in children."( Simple method to detect triclofos and its metabolites in plasma of children by combined use of liquid chromatography tandem-mass spectrometry and gas chromatography-mass spectrometry.
Hashimoto, S; Inoue, M; Ito, Y; Kamijima, M; Nakahira, Y; Nakajima, T; Sato, H, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
chloroethanolAn organochlorine compound that is ethanol substituted by at least one chloro group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
trichloroethene degradation014

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, PROTEIN (HYDROXYNITRILE LYASE)Hevea brasiliensis (rubber tree)Ki390.0000390.0000390.0000390.0000AID977610
Chain A, PROTEIN (HYDROXYNITRILE LYASE)Hevea brasiliensis (rubber tree)Ki390.0000390.0000390.0000390.0000AID977610
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
AID624619Specific activity of expressed human recombinant UGT2B72000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1811Experimentally measured binding affinity data derived from PDB1999Protein science : a publication of the Protein Society, Oct, Volume: 8, Issue:10
Three-dimensional structures of enzyme-substrate complexes of the hydroxynitrile lyase from Hevea brasiliensis.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1999Protein science : a publication of the Protein Society, Oct, Volume: 8, Issue:10
Three-dimensional structures of enzyme-substrate complexes of the hydroxynitrile lyase from Hevea brasiliensis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (171)

TimeframeStudies, This Drug (%)All Drugs %
pre-199049 (28.65)18.7374
1990's48 (28.07)18.2507
2000's48 (28.07)29.6817
2010's23 (13.45)24.3611
2020's3 (1.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.04 (24.57)
Research Supply Index5.19 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index57.12 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.14%)5.53%
Reviews3 (1.70%)6.00%
Case Studies16 (9.09%)4.05%
Observational0 (0.00%)0.25%
Other155 (88.07%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]